Highlighting prostate cancer research and innovations from Cambridge and related practice changing research in the field of cancer. RT not endorsements
Cambridge, England
Joined November 2017
- Tweets1K
- Following11
- Followers870
- Likes620
Pinned Tweet
Predict Prostate has been awarded a University of Cambridge Vice Chancellors award for research impact & public engagement - a huge honour - only possible through great teamwork @PHE_uk @paulpharoah @david_thurtle @PredictProstate @d_spiegel
The Impact of Endpoint Definitions on Predictors of Progression in Active Surveillance for Early Prostate Cancer mdpi.com/3685872 #mdpicancers via @Cancers_MDPI
Cambridge Prostate Cancer retweeted
In 2025 @PredictProstate was accessed>60,000 times worldwide to help men with early prostate cancer make informed decisions 🙌🏾- sadly still many urology teams don’t even tell their patients of it’s existence and instead give their own opinions - let’s change that @NICEComms
British Society of Urogenital Radiology (BSUR) commentary: agreement criteria for expert-level reporting during the prostate magnetic resonance imaging (MRI) learning curve - Clinical Radiology clinicalradiologyonline.net/…
Improving the Potential for Predicting Prostate Cancer Progression in Patients on Active Surveillance Using Explainable Artificial Intelligence mdpi.com/3579262 #mdpicancers via @Cancers_MDPI
Urethra contours on MRI: Multidisciplinary consensus educational atlas and reference standard for artificial intelligence benchmarking - Radiotherapy and Oncology thegreenjournal.com/article/…
LATB bx more expensive than LATRUS bx ▶️ Cost Effectiveness of Local Anaesthetic Transperineal Versus Transrectal Biopsy: Results from the TRANSLATE Study - European Urology Focus eu-focus.europeanurology.com…
Does empowering men on active surveillance for prostate cancer improve patient compliance and reduce conversion to treatment? urologynews.uk.com/features/…
Cambridge Prostate Cancer retweeted
Replicated across the @NHS this would result in very significant cost savings in fewer interventional treatments (Surgery/radiotherapy/brachytherapy/focal etc..) and reductions in cost & resource to manage treatment related morbidity. All tools free and accessible to anyone 4/4
Cambridge Prostate Cancer retweeted
The impact and benefit after implementation was clear - significant reducing in relative risk in men wit early cancers CPG1&2 going for radical treatment- CPG1 radical treatment of 6%, CPG2 radical treatment rate of 35%. Paper here : pmc.ncbi.nlm.nih.gov/article… 3/4
Cambridge Prostate Cancer retweeted
Lack of national standards on how to and what to use in counselling men with new prostate cancer drives large variations in over-treatment rates for early prostate cancer 1/4
Cambridge Prostate Cancer retweeted
Congratulations to @DrCristianIlie and colleagues on use of @CamProbe with fusion biopsy proving the versatility and accuracy of of double free hand prostate biopsies @medovate
Cambridge Prostate Cancer retweeted
Short but sweet trip to #SIU2025Edinburgh! Great to catch up with ex @CUH_NHS fellow @FP_Bizzarri presenting our work on the use of PET-CT in patients with subtype histology #bladdercancer
Link to full @EurUrolOncol paper @aw_nelson @AlexandraColqu2
👇🏽
euoncology.europeanurology.c…
Interventions for patients with prostate cancer on active surveillance: a narrative review - Gill - BJU International - Wiley Online Library bjui-journals.onlinelibrary.…
Expanding PARP Inhibitor Use in Prostate Cancer Beyond DNA Repair Defects - Clinical Oncology clinicaloncologyonline.net/a…
Active Monitoring, Surgery, and Radiotherapy for Prostate Cancer jamanetwork.com/journals/jam…
Cambridge Prostate Cancer retweeted
Validation of the Stratified Cancer Surveillance (STRATCANS) model for risk stratified cancer surveillance in prostate cancer in a large (>7500) US cohort @KBGinsburg @MUSICUrology
Radiological T-staging in prostate Cancer: Towards a universal MRI-bas... sciencedirect.com/science/ar…
Cambridge Prostate Cancer retweeted
Delighted to share our latest publication! @CamProbe versus an in-line prostate biopsy device. Head-to-head comparison!
Time to cut costs by 75% ?
@VincentGnanapr3 @kasraparsy @HannahThorman , Syed Shah, Saiful Miah
mdpi.com/2077-0383/14/16/570…
